CD40配體(CD40L)單克隆抗體
Monoclonal Antibody to Cluster Of Differentiation 40 Ligand (CD40L)
CD154; TRAP; HIGM1; IGM; IMD3; TBAM; T-BAM; TNFSF5; Gp39; TNF Superfamily Member 5; Hyper-IgM Syndrome; TNF-Related Activation Protein; T-Cell B-Cell Activating Molecule
- 編號UMAA119Hu22
 - 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
 - 來源單抗制備
 - 宿主小鼠
 - 效價(克隆號)C3
 - Ig亞型 IgG2a Kappa
 - 純化方式蛋白A + 蛋白G親和純化
 - 標記物無標記物
 - 免疫原 RPA119Hu02-CD40配體(CD40L)重組蛋白
 - 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
 - 性狀液體
 - 濃度1mg/mL
 - 且適物種-
 - 應(yīng)用IHC; ICC/IF
如果抗體需用于流式細胞術(shù),請參見流式抗體。 - 下載 英文說明書 中文說明書
 - 規(guī)格 20μl100μl 200μl 1ml 10ml
 - 價格 ¥ 302 ¥ 706 ¥ 1008 ¥ 2520 ¥ 10080
 - 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
 
特異性
該抗體是針對CD40L的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別CD40L。
用法
            Immunohistochemistry: 5-20μg/mL;
Immunofluorescence: 5-20μg/mL;
Optimal working dilutions must be determined by end user.        
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當?shù)臈l件下存儲,損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| URPA119Hu02 | CD40配體(CD40L)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| URPA119Hu04 | CD40配體(CD40L)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| URPA119Hu01 | CD40配體(CD40L)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| URPA119Hu03 | CD40配體(CD40L)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| UPAA119Hu02 | CD40配體(CD40L)多克隆抗體 | WB | 
| UPAA119Hu03 | CD40配體(CD40L)多克隆抗體 | IHC; ICC/IF | 
| UPAA119Hu01 | CD40配體(CD40L)多克隆抗體 | WB; IHC; ICC; IP. | 
| ULAA119Hu71 | CD40配體(CD40L)多克隆抗體(生物素標記) | WB; IHC; ICC. | 
| ULAA119Hu81 | CD40配體(CD40L)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. | 
| UMAA119Hu21 | CD40配體(CD40L)單克隆抗體 | IHC | 
| UMAA119Hu23 | CD40配體(CD40L)單克隆抗體 | WB | 
| UMAA119Hu22 | CD40配體(CD40L)單克隆抗體 | IHC; ICC/IF | 
| UMAA119Hu25 | CD40配體(CD40L)單克隆抗體 | IHC | 
| UMAA119Hu24 | CD40配體(CD40L)單克隆抗體 | IHC; ICC/IF | 
| URAA119Hu21 | CD40配體(CD40L)重組抗體 | WB; IF; ICC; IHC; IP; FCM. | 
| URAA119Hu22 | CD40配體(CD40L)重組抗體 | WB; IF; ICC; IHC; IP; FCM. | 
| USEA119Hu | CD40配體(CD40L)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| ULMA119Hu | CD40配體(CD40L)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
參考文獻
| 雜志 | 參考文獻 | 
| Basic Research in Cardiology | Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation [PubMed: 22899170] | 
| Molecules | The Protective Effects of Alisol A 24-Acetate from Alisma canaliculatum on Ovariectomy Induced Bone Loss in Vivo [Pubmed:26760992] | 
| Journal of Neuroinflammation | Th17-skewed immune response and cluster of differentiation 40 ligand expression in canine steroid-responsive meningitis-arteritis, a large animal model for neutrophilic meningitis. [pubmed:28114998] | 
| BMC Nephrology | Renal effects of metallothionein induction by zinc in vitro and in vivo [pubmed:28302075] | 
| Toxicology and Applied Pharmacology | Effects of diisononyl phthalate on osteopenia in intact mice [pubmed:28893586] | 
| INTERNATIONAL JOURNAL OF CARDIOLOGY | Short and long-term changes in platelet and inflammatory biomarkers after cryoballoon and radiofrequency ablation [Pubmed: 30857843] | 
| Available at SSRN 3335365? | Evaluating the Platelet Activation Related to the Degradation of Biomaterials by Scheme of Molecular Markers [] | 
| Data in Brief | Data for short and long-term prothrombotic biomarkers after cryoballoon and radiofrequency ablation [] | 
| journal of thoracic and cardiovascular surgery | Evaluating Platelet Activation Related to the Degradation of Biomaterials Using Molecular Markers [Pubmed: 32812629] | 
| Thrombosis Research | Feasibility study of use of rabbit blood to evaluate platelet activation by medical devices [Pubmed: 31838449] | 
| Cancers | Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study [Pubmed: 32085544] | 
| Persistently higher serum sCD40L levels are associated with mortality in septic patients [] | |
| Journal of Orthopaedic Translation | Tyloxapol inhibits RANKL-stimulated osteoclastogenesis and ovariectomized-induced bone loss by restraining NF-|êB and MAPK activation [33981577] | 
| Bioactive Materials | Secretions from hypochlorous acid-treated tumor cells delivered in a melittin hydrogel potentiate cancer immunotherapy [34820587] | 

                    
                    
                            